Riedel Strum: The disease described by K.L. Riedel
Riedel Struma, also known as goiter lithiasis, goiter fibrous, Riedel thyroiditis, struma ligneous, struma durumita, strumitis glandular, or thyroiditis fibrous, is a chronic thyroid disease that was first described by the German surgeon Karl Ludwig Riedel in the late 19th century.
Riedel Struma is characterized by thickening of the thyroid tissue, which usually becomes hard and immobile. This occurs due to the replacement of normal thyroid tissue with fibrous tissue, which has a sclerosing effect. As a result, the gland acquires a dense, “woody” consistency, which is a characteristic sign of this disease.
The causes of Riedel Struma are still not fully understood. However, it is believed that autoimmune processes, genetic factors and the environment may play a role in the development of the disease. Rare cases of Riedel Struma are associated with thyroid cancer.
Symptoms of Riedel Struma can vary depending on the degree of enlargement of the thyroid gland and compression of surrounding tissue. Typically, patients complain of neck enlargement, pressing pain in the thyroid area, difficulty swallowing or breathing, voice changes and problems with swallowing.
Diagnosis of Riedel Struma is usually made based on clinical symptoms as well as thyroid ultrasound and biopsy results. If thyroid cancer is suspected, additional testing may be required.
Treatment for Riedel Struma usually requires a combination of medication and surgery. The goal of treatment is to improve symptoms, reduce enlargement of the thyroid gland, and restore normal function of the organ. In some cases, complete removal of the thyroid gland may be necessary.
Riedel Struma, although a rare disease, can cause significant discomfort and disruption to patients' quality of life. Therefore, it is important to promptly consult a doctor if symptoms appear in order to receive a diagnosis and prescribe appropriate treatment.
In conclusion, Riedel Struma is a chronic thyroid disease characterized by thickening of the thyroid tissue and the formation of hard fibrous nodules. It was named after the German surgeon Carl Ludwig Riedel, who made significant contributions to the study of this condition. Riedel Struma can lead to various symptoms and limit the normal functions of the larynx, esophagus and airways.
Although the causes of Riedel Struma are not fully understood, some studies point to the possible role of autoimmune processes and genetic predisposition in the development of the disease. Environmental and nutritional factors may also influence the occurrence of Riedel Struma.
In the diagnosis of Riedel Struma, an important role is played by clinical examination, palpation of the thyroid gland and various examinations, including ultrasound and biopsy. A biopsy allows you to determine the nature of the tissue in the thyroid gland and exclude the presence of malignant tumors.
Treatment for Riedel Struma usually involves taking medications, such as thyroid hormones, which can help reduce inflammation and improve organ function. In some cases, surgery may be necessary to remove parts or all of the thyroid gland. Regular monitoring and monitoring of thyroid hormone levels is also an important part of treatment.
The prognosis for patients with Riedel Struma depends on the extent of thyroid damage and associated complications. With early diagnosis and proper treatment, most patients can achieve significant improvement and disease control.
In conclusion, Riedel Struma is a rare chronic thyroid disease that is characterized by thickening and fibrotic changes in the tissue of the organ. Timely diagnosis and treatment are key aspects of managing this condition and improving patients' quality of life.